首页> 外国专利> Derivatives Indan - 1 - trees replaced in C2, Process for their Preparation and their use as Drugs, Medicine, Process for the preparation of a Medicine, and use of said derivatives alone or in combination with another active substance, for the preparation of medicaments

Derivatives Indan - 1 - trees replaced in C2, Process for their Preparation and their use as Drugs, Medicine, Process for the preparation of a Medicine, and use of said derivatives alone or in combination with another active substance, for the preparation of medicaments

机译:在C2中取代的Indan-1-树木,其制备方法及其用作药物,药物,药物制备方法,以及单独或与其他活性物质组合使用所述衍生物制备药物

摘要

1. The indan-1-ole derivative is replaced in C2 equation (1), which means (a) R1 to R4, h; X is s, so, or SO2; y is (CH2) P, where p can be equal to 0, 1, 2 or 3; R5 is CF3, c12-18, cyclo-4, cyclo-c6-8, which can be converted into fluorine by one to seven hydrogen atoms in tar group; (CH2) r-cor6, may be r = 1-6, may be R6, equivalent to Oh, o-tar C1-6 or NH2; ch2-ch (nhr7) - cor8, may be R7, equivalent to h, C (or) - C1-4 or C (or) C1-4 tar, and may be R8, equivalent to Oh, o-tar C1-6 or NH2; phenyl, 1-o-2-naftio, biphenyl or a heterosexual radical substance,the rings or ring systems may be substituted up to twice with O-C 1-8 alkyl, O-C 3-8 cycloalkyl, O-CO-C 1-8 alkyl, O-CO-C 3-8 cycloalkyl, S (O) 0 -2-C1-8-alkyl, S (O) 0-2-C3-8-cycloalkyl, NH2, NH-C1-8-alkyl, NH-C3-8-cycloalkyl, N [C1-8-alkyl] 2, N [C3-cycloalkyl -8] 2, NH-CO-C2-8-alkyl, NH-CO-C3-8-cycloalkyl, SO3H, SO2-NH2, SO2-NH-C1-8-alkyl, SO2-NH-C3-8-cycloalkyl, NH-SO2 -NH2, NH-SO2-C1-8-alkyl, NH-SO2-C3-8 cycloalkyl, O-CH2-COOH, O-CH2-CO-O-C1-8-alkyl, COOH, CO-O-C1-8-alkyl , CO-O-C3-8cycloalkyl, CO-NH2, CO-NH-C1-8alkyl, CO-N- [C1-8alkyl] 2, C1-8alkyl, C3-8cycloalkyl,In each case, as many as seven hydrogen atoms in the tar group can be replaced by fluorine; F, Cl, Br, I, CN; but excluding the meaning of unsubstituted phenyl, 4-fluoroofenenio, 4-bromophenyl, 4-chlorophenyl, 3-methylphenyl, 4-methylphenyl, 4-methoxyphenyl, 4-n-butylphenyl, 4-t-butylphenyl, 2-amino, 2. C12; or (b) R1, R4, which are independent of each other, are h; F, Cl, Br, I; CN; N3, NO2, oh, o-c1-8, o-cycloquilo (C3-4 and c6-8),O-CH2-phenyl, O-phenyl, O-CO-C1-8-alkyl, O-CO-C3-8-cycloalkyl, S (O) 0-2-C1-8-alkyl, S (O) 0-2-cycloalkyl C3-8, NH2, NH-C1-8-alkyl, NH-C3-8-cycloalkyl, N [C1-8-alkyl] 2, N [C3-8-cycloalkyl] 2, NH-CO-C1-8-alkyl, NH-CO -C3-8cycloalkyl, SO3H, SO2-NH2, SO2-NH-C1-8alkyl, SO2-NH-C3-8cycloalkyl, NH-SO2-NH2, NH-SO2-C1-8alkyl, NH-SO2-cycloalkyl C3-8, O-CH2-COOH, O-CH2-CO-O-C1-8-alkyl, COOH, CO-O-C1-8-alkyl, CO-O-C3-8-cycloalkyl, CO-NH2, CO-NH -C1-8alkyl, CO-N- [C1-8alkyl] 2, C1-8alkyl, C3-8cycloalkyl, C2-8alkenyl, or C2-8alkynyl, being able to be substituted in the alkyl groups,3 - [lil] - 3 - [3] - 3,2-3,2-3 - [3-3-2-3] - 3-3 - [seamless 2 - or 3-folio, 23-or 4-pyridine, 2-4-or 5-oxazolilo, 3-4-or 5-isoxazolilo, 2-4-or 5-thiazole, 34- or 5-isothiazolyl, the aryl or heterocycle radical may be substituted up to twice with F, Cl, Br, CN, OH, C1-4 alkyl, CF3, O-C1-4 alkyl, S (O) 0-2 -C1-6alkyl, NH2, NH-SO2-C1-4alkyl, COOH, CO-O-C1-4alkyl, or CO-NH2 and one to seven hydrogen atoms may be replaced by fluorine in the alkyl groups; R2, R3 independently of one another are H; F, Cl, Br, I; CN; N3, NO2, O-C1-8-alkyl, O-C3-8-cycloalkyl, O-CO-C1-8-alkyl, O-CO-C3-8-cycloalkyl, S (O) 0-2-C1-8-alkyl, S (O) 0-2-C3-8cycloalkyl, NH2, NH-C1-8alkyl, NH-C3-8cycloalkyl, N [C1-8alkyl] 2, N [C3-8cycloalkyl] 2, NH-CO- C1-8alkyl, NH-CO-C3-8cycloalkyl, SO3H, SO2-NH2,SO2-NH-C5-8-alkyl, SO2-NH-C3-8-cycloalkyl, NH-SO2-NH2, NH-SO2-C1-8-alkyl, NH-SO2-C5-8-cycloalkyl, O-CH2-COOH, O- CH2-CO-O-C1-8-alkyl, COOH, CO-O-C1-8-alkyl, CO-O-C3-8-cycloalkyl, CO-NH2, CO-NH-C1-8-alkyl, CO-N [C1-alkyl -8] 2, C1-8-alkyl, C3-8-cycloalkyl, C2-8-alkenyl, C2-8-alkynyl, the alkyl, alkenyl and alkynyl groups being able to be substituted in each case one to seven hydrogen atoms by fluorine; or a hydrogen may be replaced by OH, OC (O) CH3, O-CH2-Ph, NH2, NH-CO-CH3 or N (COOCH2Ph) 2; phenyl, 1- or 2-naphthyl, 5-tetrazolyl, 1- [C1-6alkyl] -5-tetrazolyl, 2- [C1-6alkyl] -5-tetrazolyl, 1-imidazolyl, 1- or 4- [1 2,4] triazolyl,2 Three, two, three, fuliou, two3-or 4-pyridine, 2-4-or 5-oxazolilo, 3-4-or 5-isoxazolilo, 2-4-or 5-thiazole, 34-O 5-isothiocyanides can be replaced by F, Cl, Br, CN, oh, C1-4 tar, CF3, or C1-4, s (o) 0-2-tar C1-6, NH2, nh-so2-c1-4, COOH, co-O C1-4 or co-nh2 for two heterocycles, and one to seven hydrogen atoms can be replaced by fluorine in tar group; O R2 and R3 constitute an o-ch2-o group;At least one of the R1, R2, R3 and R4 type radicals does not contain hydrogen; X is s, so, so or SO2 type; and it is (CH2) P type radical, whose quantity is equivalent to 0, 1, 2 or 3; R5 is c1-18 asphalt, or cyclomequillo (C3-4 and c6-8),in the alkyl groups, one to seven hydrogen atoms may be replaced by fluorine; (CH2) r-COR6, where r = 1-6 can be and R6 can be equal to OH, O-C1-6 alkyl or NH2; CH2-CH (NHR7) -COR8, R7 being equal to H, C (O) -C1-6 alkyl or C (O) O-C1-6 alkyl and R8 being equal to OH, O-C1-6 alkyl or NH2; phenyl, 1- or 2-naphthyl, biphenyl or a heterocyclic radical, the rings or ring systems may be substituted up to twice with O-C 1-8 alkyl, O-C 3-8 cycloalkyl, O-CO-C 1-8 alkyl , O-CO-C3-8 cycloalkyl, S (O) 0-2-C1-8-alkyl, S (O) 0-2-C3-8-cycloalkyl, NH2, NH-C1-8-alkyl, NH-C3-cycloalkyl 8, N [C1-8 alkyl] 2, N [C3-8 cycloalkyl] 2,Or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or or lo C3-8, co-nh2, co-nh-tar c1-8, Co-N [c1-8 tar] 2, c1-8 tar, cycloquinolo C3-8, may already exist In each case, up to seven hydrogen atoms are replaced by fluorine in each group of aspha F, Cl, Br, I or CN and their physiologically compatible salts; their preparation and procedures for use as drugs, drugs and drugs;Use of these derivatives or in combination with other active substances for the prevention or treatment of obesity and type II diabetes.
机译:1.在C2方程式(1)中取代茚满-1-烯衍生物,其含义是(a)R1至R4,h; X是s,所以是SO2; y是(CH2)P,其中p可以等于0、1、2或3; R5为CF3,c12-18,环4,环-c6-8,它们可以被焦油基团中的1至7个氢原子转化为氟; (CH2)r-cor6,可以是r = 1-6,可以是R6,相当于Oh,o-tar C1-6或NH2; ch2-ch(nhr7)-cor8,可以是R7,相当于h,C(或)-C1-4或C(或)C1-4焦油,并且可以是R8,相当于Oh,o-tar C1-6或NH2;苯基,1-o-2-萘基,联苯或异性自由基物质,其环或环系统最多可被OC 1-8烷基,OC 3-8环烷基,O-CO-C 1-8烷基取代两次,O-CO-C 3-8环烷基,S(O)0 -2-C1-8-烷基,S(O)0-2-C3-8-环烷基,NH2,NH-C1-8-烷基,NH -C3-8-环烷基,N [C1-8-烷基] 2,N [C3-环烷基-8] 2,NH-CO-C2-8-烷基,NH-CO-C3-8-环烷基,SO3H,SO2 -NH2,SO2-NH-C1-8-烷基,SO2-NH-C3-8-环烷基,NH-SO2--NH2,NH-SO2-C1-8-烷基,NH-SO2-C3-8环烷基,O- CH2-COOH,O-CH2-CO-O-C1-8-烷基,COOH,CO-O-C1-8-烷基,CO-O-C3-8环烷基,CO-NH2,CO-NH-C1-8烷基, CO-N- [C 1-8烷基] 2,C 1-8烷基,C 3-8环烷基,在每种情况下,焦油基团中多达七个氢原子可以被氟取代; F,Cl,Br,I,CN;但不包括未取代的苯基,4-氟烯,4-溴苯基,4-氯苯基,3-甲基苯基,4-甲基苯基,4-甲氧基苯基,4-正丁基苯基,4-叔丁基苯基,2-氨基,2的含义。 C12; (b)彼此独立的R1,R4为h;或F,Cl,Br,I; CN; N3,NO2,哦,o-c1-8,o-环喹啉(C3-4和c6-8),O-CH2-苯基,O-苯基,O-CO-C1-8-烷基,O-CO-C3 -8-环烷基,S(O)0-2-C1-8-烷基,S(O)0-2-环烷基C3-8,NH2,NH-C1-8-烷基,NH-C3-8-环烷基, N [C1-8-烷基] 2,N [C3-8-环烷基] 2,NH-CO-C1-8-烷基,NH-CO-C3-8环烷基,SO3H,SO2-NH2,SO2-NH-C1- 8烷基,SO2-NH-C3-8环烷基,NH-SO2-NH2,NH-SO2-C1-8烷基,NH-SO2-环烷基C3-8,O-CH2-COOH,O-CH2-CO-O-C1-8 -烷基,COOH,CO-O-C1-8-烷基,CO-O-C3-8-环烷基,CO-NH2,CO-NH-C1-8烷基,CO-N- [C1-8烷基] 2,C1-可以被烷基取代的8-烷基,C3-8环烷基,C2-8链烯基或C2-8炔基3- [lil]-3-[3]-3,2-3,2-3-[3- 3-2-3]-3-3-[无缝2-或3-对开,23-或4-吡啶,2-4-或5-恶唑利洛,3-4-或5-异恶唑,2-4-或5-噻唑,34-或5-异噻唑基,芳基或杂环基最多可被F,Cl,Br,CN,OH,C1-4烷基,CF3,O-C1-4烷基,S(O )0-2 -C1-6烷基,NH2,NH-SO2-C1-4烷基,COOH,CO-O-C1-4烷基或CO-NH2烷基中的1至7个氢原子可以被氟取代; R2,R3彼此独立地为H; F,Cl,Br,I; CN; N3,NO2,O-C1-8-烷基,O-C3-8-环烷基,O-CO-C1-8-烷基,O-CO-C3-8-环烷基,S(O)0-2-C1- 8-烷基,S(O)0-2-C3-8环烷基,NH2,NH-C1-8烷基,NH-C3-8环烷基,N [C1-8烷基] 2,N [C3-8环烷基] 2,NH-CO- C1-8烷基,NH-CO-C3-8环烷基,SO3H,SO2-NH2,SO2-NH-C5-8-烷基,SO2-NH-C3-8-环烷基,NH-SO2-NH2,NH-SO2-C1- 8-烷基,NH-SO2-C5-8-环烷基,O-CH2-COOH,O-CH2-CO-O-C1-8-烷基,COOH,CO-O-C1-8-烷基,CO-O- C3-8-环烷基,CO-NH2,CO-NH-C1-8-烷基,CO-N [C1-烷基-8] 2,C1-8-烷基,C3-8-环烷基,C2-8-烯基, C 2-8-炔基,所述烷基,烯基和炔基在每种情况下可被氟取代1至7个氢原子;或者氢可以被OH,OC(O)CH 3,O-CH 2 -Ph,NH 2,NH-CO-CH 3或N(COOCH 2 Ph)2代替;苯基,1-或2-萘基,5-四唑基,1- [C1-6烷基] -5-四唑基,2- [C1-6烷基] -5-四唑基,1-咪唑基,1-或4- [1 2, 4]三唑基,2三,二,三,氟,两个3-或4-吡啶,2-4-或5-恶唑利洛,3-4-或5-异恶唑利,2-4-或5-噻唑,34-O 5-异硫氰化物可替换为F,Cl,Br,CN,oh,C1-4焦油,CF3或C1-4,s(o)0-2-tar C1-6,NH2,nh-so2-c1- 4,COOH,co-O C1-4或co-nh2两个杂环,并且焦油基团中的一个到七个氢原子可以被氟取代; O R2和R3构成一个o-ch2-o基团; R1,R2,R3和R4型基团中的至少一个不含氢; X是s,所以是so2类型; (CH2)P型基团,其数量等于0、1、2或3; R 5是c 1-18沥青或环mequillo(C 3-4和c 6-8),在烷基中,一个至七个氢原子可以被氟取代; (CH2)r-COR6,其中r = 1-6可以为且R6可以等于OH,O-C1-6烷基或NH2; CH2-CH(NHR7)-COR8,R7等于H,C(O)-C1-6烷基或C(O)O-C1-6烷基,R8等于OH,O-C1-6烷基或NH2 ;苯基,1-或2-萘基,联苯基或杂环基,其环或环系统最多可被OC 1-8烷基,OC 3-8环烷基,O-CO-C 1-8烷基,O取代两次-CO-C3-8环烷基,S(O)0-2-C1-8-烷基,S(O)0-2-C3-8-环烷基,NH2,NH-C1-8-烷基,NH-C3-环烷基8,N [C1-8烷基] 2,N [C3-8环烷基] 2,或或或或或或或或或或或或或或或或或或或或或或或或或或或或or或or或or或或or或or或or或lo C3-8,co-nh2,co-nh-tar c1-8,Co-N [c1-8焦油] 2,c1-8焦油,环喹啉C3-8可能已经存在。在每种情况下,每组沥青中最多有七个氢原子被氟取代; F,Cl,Br,I或CN及其生理相容性盐;它们的制备和用作药物,药物和药物的程序;这些衍生物或与其他活性物质联合用于预防或治疗肥胖症和II型糖尿病的用途。

著录项

  • 公开/公告号AR036676A1

    专利类型

  • 公开/公告日2004-09-29

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMA DEUTSCHLAND GMBH;

    申请/专利号AR2002P103252

  • 发明设计人

    申请日2002-08-29

  • 分类号C07C317/20;C07C323/17;A61K31/10;A61P3/04;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号